Cancer Services

238. Deputy Tom Brabazon asked the Minister for Health the actions her Department is taking to ensure the development of networked services and multidisciplinary teams, as recommended in the national cancer control programme in the hereditary cancer model of care, HSE national cancer control programme. [34962/25]

239. Deputy Tom Brabazon asked the Minister for Health the actions she is taking to ensure workforce development, as recommended in the national cancer control programme in the hereditary cancer model of care, HSE national cancer control programme. [34963/25]

240. Deputy Tom Brabazon asked the Minister for Health the actions her Department is taking to ensure there is patient information and supports for those under the hereditary cancer model of care. [34964/25]

241. Deputy Tom Brabazon asked the Minister for Health the actions her Department is taking to provide patient information and supports, as recommended in the national cancer control programme in the hereditary cancer model of care, HSE national cancer control programme. [34965/25]

242. Deputy Tom Brabazon asked the Minister for Health the actions her Department has taken to identify the IT infrastructure required to enable the implementation of this hereditary cancer model of care, including genetic counselling network and referral to national specialist genetics multidisciplinary teams. [34966/25]

749. Deputy Colm Burke asked the Minister for Health to clarify the options available to women who have cancer and require breast surgery as regards their access to support services including breast protheses, and, in particular, whether they can attend any facility which is approved by the HSE regardless of where they are located; and if she will make a statement on the matter. [33533/25]

752. Deputy Jennifer Whitmore asked the Minister for Health to provide the details of funding being allocated to each cancer support service (as announced by her predecessor in October 2024), by county, in 2025; to specify whether this funding is recurrent; when each service will receive this funding; and if she will make a statement on the matter. [33570/25]

865. Deputy David Cullinane asked the Minister for Health the operational status of the National Cervical Screening Laboratory; the timeframe from commencement to completion and opening; the cost of the development to date; the cost of operations to date; the full capacity staffing requirements for the laboratory and the unmet staffing need; the level of activity through the laboratory, by year; a…

866. Deputy David Cullinane asked the Minister for Health the number of cancer screening samples, by type, which have been processed domestically by public health services, domestically by private services, and which have been outsourced internationally, by location or service, in tabular form. [32426/25]

933. Deputy Pádraig Rice asked the Minister for Health to outline the status of each cancer-related capital programme, in tabular form; and if she will make a statement on the matter. [32776/25]

934. Deputy Pádraig Rice asked the Minister for Health to specify which cancer-related capital programmes reached appraisal stage and have now lapsed in each of the years 2020 to 2024 and to date in 2025, in tabular form; and if she will make a statement on the matter. [32777/25]

935. Deputy Pádraig Rice asked the Minister for Health to outline the status of each of the promised dedicated cancer units; and if she will make a statement on the matter. [32778/25]

528. Deputy David Cullinane asked the Minister for Health if her attention has been drawn to of concerns regarding post surgical complications on children in oncology services at CHI; if she was made aware of instances of prolonged recoveries for children following complications; the numbers of children involved; if she is aware if the families of those children were notified of the reasons for th…

529. Deputy David Cullinane asked the Minister for Health if her attention has been drawn to paediatric oncology patients at CHI having a poor experience or being harmed, due to the inability of CHI to deliver international best practice standards of paediatric surgical oncology provision; if so, the action she has taken; and if she will make a statement on the matter. [31474/25]

1288. Deputy Mattie McGrath asked the Minister for Health when a new cancer medication (details supplied), which has been approved by the European Medicines Agency, will be approved in Ireland and included in the HSE reimbursement scheme; the reason for the delay in including this medication in the reimbursement scheme; and if she will make a statement on the matter. [29101/25]

1316. Deputy Michael Cahill asked the Minister for Health the measures that are being taken to detect breast cancer at the earliest possible time; and if she will make a statement on the matter. [29157/25]

1325. Deputy Liam Quaide asked the Minister for Health her plans to ensure a fast-tracked review of VYLOY (zolbetuximab-clzb) for inclusion in the HSE reimbursement scheme; and if she will make a statement on the matter. [29201/25]

1407. Deputy Denise Mitchell asked the Minister for Health the status of the Hereditary Cancer Model of Care in Ireland; the funding that has been provided for this initiative and the plans for future funding; and if she will make a statement on the matter. [29534/25]

1408. Deputy Denise Mitchell asked the Minister for Health if genetic testing is yet available to close relatives of those diagnosed with pancreatic cancer in order to detect genetic mutations and aid in early diagnosis and prevention; and if she will make a statement on the matter. [29535/25]

1440. Deputy Séamus McGrath asked the Minister for Health urgent approval will be granted for the drug vyloy (zolbetuximab) which is used for certain types of gastric and gastroesophageal junction cancers (details supplied); and if she will make a statement on the matter. [29662/25]

1522. Deputy Barry Heneghan asked the Minister for Health her plans to develop a new National Cancer Strategy, as the current strategy concludes at the end of 2026; what specifically will be done to ensure that a wide range of stakeholders are consulted in developing a new Strategy; and if she will make a statement on the matter. [30014/25]

1556. Deputy Barry Ward asked the Minister for Health if her attention has been drawn to the concerns of the cancer patient advocacy group (details supplied) regarding the provision of cancer treatment drugs; and if she will make a statement on the matter. [30174/25]

1561. Deputy Naoise Ó Muirí asked the Minister for Health if she will provide an update on the implementation of the Model of Care for Hereditary Cancer, the National Strategy for Accelerating Genetic and Genomic Medicine; and if she will make a statement on the matter. [30206/25]

368. Deputy Ken O'Flynn asked the Minister for Health if she will consider approving coverage for a type of treatment (details supplied) as a matter of urgency, given the potentially life-saving impact; whether she intends to provide funding for vyloy through the HSE, or under the medical card scheme, for cases where it is clinically indicated; and if she will make a statement on the matter. [2778…

387. Deputy Pat Buckley asked the Minister for Health to allocate funding to all local authorities and Government Departments to install suncream dispensers in all public buildings, including schools and third level institutes, to help normalise the application of sun cream and strive to reduce the instances of skin cancer in Ireland. [27886/25]